Cargando…

Silibinin improves nonalcoholic fatty liver by regulating the expression of miR-122: An in vitro and in vivo study

Silibinin is a flavonoid that improves fatty liver and insulin resistance. To elucidate the effect of silibinin on lipid deposition and the potential molecular mechanism, the present study conducted in vivo and in vitro experiments. In the in vivo experiments, mice were randomly divided into control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Liying, Liu, Qianqian, Zhang, He, Wang, Yichao, Li, Yang, Chen, Shuchun, Song, Guangyao, Ren, Luping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974327/ https://www.ncbi.nlm.nih.gov/pubmed/33760189 http://dx.doi.org/10.3892/mmr.2021.11974

Ejemplares similares

Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice
por: Wang, Yichao, et al.
Publicado: (2022)

The Effect of Silibinin on Protein Expression Profile in White Adipose Tissue of Obese Mice
por: Wang, Fei, et al.
Publicado: (2020)

Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease
por: Sun, Tiantian, et al.
Publicado: (2023)

A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test
por: Hou, Xiaoyu, et al.
Publicado: (2021)

miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2016)

Liraglutide suppresses obesity and promotes browning of white fat via miR-27b in vivo and in vitro
por: Wang, Xing, et al.
Publicado: (2021)

Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma
por: Akuta, Norio, et al.
Publicado: (2016)

Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Song, Tiantian, et al.
Publicado: (2021)

miR−122−5p Regulates Renal Fibrosis In Vivo
por: Kaneko, Shohei, et al.
Publicado: (2022)

Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
por: Israelow, Benjamin, et al.
Publicado: (2014)

The effects of hepatitis C virus core protein on the expression of miR-122 in vitro
por: Li, Sujuan, et al.
Publicado: (2013)

Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
por: Cufí, Sílvia, et al.
Publicado: (2013)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Comparing the effectiveness of long-term use of daily and weekly glucagon-like peptide-1 receptor agonists treatments in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus: a network meta-analysis
por: Yuan, Xia, et al.
Publicado: (2023)

Antioxidant and Hepatoprotective Effects of Silibinin in a Rat Model of Nonalcoholic Steatohepatitis
por: Haddad, Yara, et al.
Publicado: (2011)

Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease
por: Salvoza, Noel C., et al.
Publicado: (2016)

Circulating Bone Morphogenetic Protein-9 is Decreased in Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
por: Hao, Jianan, et al.
Publicado: (2022)

MiR-122 Promotes the Development of Colon Cancer by Targeting ALDOA In Vitro
por: Li, Hong, et al.
Publicado: (2019)

Silibinin treatment prevents endotoxin-induced uveitis in rats in vivo and in vitro
por: Chen, Ching-Long, et al.
Publicado: (2017)

miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
por: López, Paulina, et al.
Publicado: (2018)

Characterization of miR-122-independent propagation of HCV
por: Ono, Chikako, et al.
Publicado: (2017)

Regulation of hepatic glutamine metabolism by miR-122
por: Sengupta, Dipanwita, et al.
Publicado: (2020)

Smoking behavior and circulating vitamin D levels in adults: A meta‐analysis
por: Yang, Lu, et al.
Publicado: (2021)

Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome
por: Li, Xiangdong, et al.
Publicado: (2015)

miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2
por: Li, Xiao-Na, et al.
Publicado: (2020)

Silibinin Ameliorates O-GlcNAcylation and Inflammation in a Mouse Model of Nonalcoholic Steatohepatitis
por: Lee, Su Jin, et al.
Publicado: (2018)

Kinetics of miR-122 Expression in the Liver during Acute HCV Infection
por: Choi, Youkyung, et al.
Publicado: (2013)

Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease
por: Shen, Nan, et al.
Publicado: (2023)

Isoschaftoside Reverses Nonalcoholic Fatty Liver Disease via Activating Autophagy In Vivo and In Vitro
por: Su, Yanze, et al.
Publicado: (2022)

Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
por: Yao, Jiayin, et al.
Publicado: (2013)

Synergistic anticancer effects of nanocarrier loaded with berberine and miR-122
por: Li, Lei, et al.
Publicado: (2018)

The Roles of Epinephelus coioides miR-122 in SGIV Infection and Replication
por: Sun, Hong-Yan, et al.
Publicado: (2021)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
por: Amr, Khalda S., et al.
Publicado: (2017)

Role of miR-122 and lipid metabolism in HCV infection
por: Fukuhara, Takasuke, et al.
Publicado: (2012)

Serum miR-122 correlates with short-term mortality in sepsis patients
por: Wang, Huijuan, et al.
Publicado: (2014)

Deregulation of miR-21 and miR-155 and their putative targets after silibinin treatment in T47D breast cancer cells
por: Zadeh, Masoud Maleki, et al.
Publicado: (2015)

Potential relative quantities of miR-122 and miR-150 to differentiate hepatocellular carcinoma from liver cirrhosis
por: Gumilas, Nur Signa Aini, et al.
Publicado: (2022)

Lrp6 Genotype affects Individual Susceptibility to Nonalcoholic Fatty Liver Disease and Silibinin Therapeutic Response via Wnt/β-catenin-Cyp2e1 Signaling
por: Chen, Li-Jie, et al.
Publicado: (2021)

MicroRNA-122 Regulation of HCV Infections: Insights from Studies of miR-122-Independent Replication
por: Panigrahi, Mamata, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kkq0b9kd3irk8lpgbgmap9h6ra